Aspira Womens Health Company Overview
About Aspira Womens Health
Aspira Women's Health (NASDAQ:AWH) focuses on innovating healthcare solutions specifically tailored for women. With a strong emphasis on gynecologic and reproductive health, Aspira aims to revolutionize the diagnosis and treatment of women’s health issues through the development and marketing of unique diagnostic tests and bioinformatics. The company's projects include the advancement of ovarian cancer screening tests that hold the promise of early detection, potentially leading to better outcomes for patients. Aspira's objective is to become a household name in women's health by providing reliable, cutting-edge solutions for healthcare providers and their patients, empowering women to take charge of their health with confidence and informed choice.
Snapshot
Operations
Produtos e/ou serviços de Aspira Womens Health
- OVA1Plus is a risk assessment test for ovarian cancer, evaluating protein levels to aid in diagnosis.
- Aspira Synergy uses artificial intelligence to enhance the performance of diagnostics in women's health.
- EndoCheck assesses the risk of endometriosis through a blood test, facilitating early detection and treatment.
- OvaWatch is aimed at predicting the risk of ovarian cancer before symptoms appear, focusing on prevention.
- Genetic testing for hereditary cancer risks, providing personalized risk assessment and management strategies.
- Aspira Labs offers a range of diagnostic services, specializing in gynecological health, improving accuracy and efficiency.
equipe executiva do Aspira Womens Health
- Ms. Nicolette PossematoSenior Vice President of Human Resources
- Ms. Michelle SniderSenior Vice President of Commercial Strategy & Operations
- Ms. Jamie L. SullivanChief of Staff & ARPA-H Program Director